glp-1 diarrhea lawsuit in west virginia The FDA has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, patients who took its medications, popularly known as Ozempic and Mounjaro Lawsuit - July 2026

And this is where it helps to expand what we mean by progress, because it doesnt always look dramatic In social media, fitness, culture, progress is often portrayed as huge jumps in weight lifted or dramatic physical transformations

The substantial weight loss these medications produce can include loss of lean muscle mass alongside fat, which has implications for long-term metabolic health and physical function

Osteoporosis is far more seriousand far more commonthan most people realize

As drug prices rise due to inflation-driven manufacturing and distribution costs, patients may delay or forgo treatment, especially in markets with limited insurance coverage

Wegovy and Zepbound are covered by approximately 40-50% of commercial plans up significantly from 2023-2024

So the idea that food and nutrients influence your GLP-1 system isn't fantasy it's basic physiology